Author

Sara Little

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Andrew J. DannenbergiD· 1 shared Benjamin A. MayesiD· 1 shared Bradley J. CarveriD· 1 shared Douglas V. GuzioriD· 1 shared James M. ShanahaniD· 1 shared John S. PeterseniD· 1 shared Peter Klaus CorneliusiD· 1 shared Pierre J. DufouriD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andrew J. DannenbergORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Evexomostat (SDX-7320), a Methionine Aminopeptidase Type 2 (METAP2) Inhibitor, Stimulates Weight Loss and Inhibits Obesity-Accelerated Tumor Growth

Peter Klaus Cornelius, Benjamin A. Mayes, Andrew J. Dannenberg, Pierre J. Dufour, Sara Little, Douglas V. Guzior, John S. Petersen, James M. Shanahan, Bradley J. Carver

This study shows that SDX-7320, a METAP2 inhibitor, reduces obesity-accelerated tumor growth in mice through both direct anti-tumor effects and indirect metabolic improvements.

Frontiers in Oncology · Feb 18, 2026Peer-reviewedCancer Biology